RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Albany, NY · Laurelton, NY · Long Island City, NY · +53 more sites
2 recruiting type 2 diabetes studies with a site in Long Island City, NY.
All trials in Long Island City, NY · All Type 2 Diabetes trials
Sponsor: AstraZeneca
Albany, NY · Laurelton, NY · Long Island City, NY · +53 more sites
Sponsor: Eli Lilly and Company
Long Island City, NY · Staten Island, NY · West Seneca, NY · +22 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.